Planned sale of 31,082 LUNG shares disclosed by holder (NASDAQ: LUNG)

Rhea-AI Filing Summary

A shareholder of LUNG has filed a notice of proposed sale under Rule 144 to sell 31,082 common shares through Morgan Stanley Smith Barney LLC. The filing lists an aggregate market value of 62,073.62 for these shares, with an approximate sale date of January 14, 2026 on NASDAQ. The notice also shows that 41,247,034 common shares are outstanding and that the shares to be sold were acquired via restricted stock, open market purchases, and an employee stock purchase plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	31082	62073.62	41247034	01/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/03/2025	Restricted Stock	Issuer			11837	03/03/2025	Not Applicable
Common	08/20/2024	Open Market Purchase	Issuer			14245	08/20/2024	Cash
Common	08/15/2025	Employee Stock Purchase Plan	Issuer			2500	08/15/2025	Cash
Common	02/21/2025	Employee Stock Purchase Plan	Issuer			2500	02/21/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for LUNG disclose?

The Form 144 filing discloses that a shareholder intends to sell 31,082 shares of LUNG common stock, with an aggregate market value of 62,073.62, on or about January 14, 2026 on NASDAQ.

How many LUNG shares are planned to be sold and through which broker?

The notice covers the proposed sale of 31,082 common shares of LUNG through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, NY 10004.

What is the stated market value of the LUNG shares to be sold?

The filing reports an aggregate market value of 62,073.62 for the 31,082 LUNG common shares that are proposed to be sold.

How many LUNG shares are outstanding according to the Form 144?

The Form 144 indicates that there are 41,247,034 common shares of LUNG outstanding.

How were the LUNG shares being sold under Form 144 originally acquired?

The shares were acquired through a mix of restricted stock (11,837 shares on 03/03/2025), an open market purchase (14,245 shares on 08/20/2024), and employee stock purchase plan purchases (2,500 shares on 02/21/2025 and 2,500 shares on 08/15/2025).

On which exchange will the LUNG shares described in the Form 144 be sold?

The Form 144 specifies that the LUNG common shares are expected to be sold on the NASDAQ stock market.

What type of security is covered in LUNG’s Form 144 notice?

The notice relates to sales of common stock of LUNG under Rule 144.